J
Joseph L. Izzo
Researcher at University at Buffalo
Publications - 232
Citations - 53804
Joseph L. Izzo is an academic researcher from University at Buffalo. The author has contributed to research in topics: Blood pressure & Systolic hypertension. The author has an hindex of 46, co-authored 229 publications receiving 51755 citations. Previous affiliations of Joseph L. Izzo include Erie County Medical Center & LSU Health Sciences Center New Orleans.
Papers
More filters
Journal ArticleDOI
Hemodynamic Effects of Sacubitril-Valsartan Versus Enalapril in Patients With Heart Failure in the EVALUATE-HF Study: Effect Modification by Left Ventricular Ejection Fraction and Sex.
Gary F. Mitchell,Scott D. Solomon,Amil M. Shah,Brian Claggett,James C. Fang,Joseph L. Izzo,Cheryl A. Abbas,Akshay S. Desai,Evaluate-Hf Investigators +8 more
TL;DR: In this paper, treatment with sacubitril-valsartan reduces mortality and heart failure (HF) events in HF with reduced ejection fraction and may reduce HF hospitalization in women with HF with preserve...
Journal ArticleDOI
Combined aliskiren-amlodipine treatment for hypertension in African Americans: clinical science and management issues.
Joseph L. Izzo,Adrienne S. Zion +1 more
TL;DR: New trends in race-based research are examined; the weaknesses of race- based treatment recommendations are emphasized; and the effects of a new combination, renin inhibition (aliskiren) and amlodipine, in African Americans are explored.
Journal ArticleDOI
Humoral effect of norepinephrine on renin release in humans.
Mark R. Licht,Joseph L. Izzo +1 more
TL;DR: The differential effect of alpha-agonists on PRA defines an important humoral effect of NE, which should be considered to be a "cardiovascular hormone."
Journal ArticleDOI
Pitfalls of Pulse Wave Analysis and Oscillometric Blood Pressure Derivatives
Joseph L. Izzo,Gary F. Mitchell +1 more
Journal ArticleDOI
Are there benefits of antihypertensive therapy beyond blood pressure lowering
TL;DR: Meta-analyses strongly suggest that the primary preventive benefit of antihypertensive therapy in uncomplicated individuals is the direct result of the lower blood pressure rather than the choice of agents.